Literature DB >> 30926907

Novel antibody-based reversal agent for ticagrelor.

Karina Huynh1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30926907     DOI： 10.1038/s41569-019-0191-4

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  2 in total

1.  Cardiovascular Risk Reduction with Icosapent Ethyl. Reply.

Authors:  Deepak L Bhatt; P Gabriel Steg; Michael Miller
Journal:  N Engl J Med       Date:  2019-04-25       Impact factor: 91.245

Review 2.  Reversal agents for non-vitamin K antagonist oral anticoagulants.

Authors:  Jerrold H Levy; James Douketis; Jeffrey I Weitz
Journal:  Nat Rev Cardiol       Date:  2018-01-18       Impact factor: 32.419
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.